GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.03G135300	P42432	Phthalsaurediethylhexylester	4	2.60592381100243e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44498	PA(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)-OH(19S))	4	1.98521721495788e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44506		4	1.64514145636233e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P10273	5-Imino-2-methyl-1-cyclopenten-1-ol	3	2.02472013243676e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P17751		3	3.46051265937339e-15	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P26792	2-Methoxybenzoic acid	3	2.95519778949239e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37460	Consiculine	3	2.93903310810613e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42164	Levallorphan	3	9.57337540118994e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42908		3	9.14828225205434e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44457	Montanastatin	3	3.89432895398965e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P47033	Xenortide A	3	3.31524153052103e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P01737	Nicotinate D-ribonucleoside	2	4.63396038396875e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P03988		2	9.8630902336013e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P10026	Luteolin 3'-methyl ether 7-glucuronide-4'-rhamnoside	2	3.02652939772821e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P10857	n-propylthiouracil	2	6.66286876407019e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P13624	OR-1896	2	2.24743452078692e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P16053	Luteolin 7-galacturonide-4'-glucoside	2	7.00476723216721e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37789	Acetyljujuboside B	2	6.32715526539015e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38074	1-(2-methoxy-tetracosanyl)-sn-glycero-3-phosphoserine	2	8.3240013665074e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42062	(2S,3R)-3-Butan-2-yl-N-hydroxy-N'-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-2-prop-2-enylbutanediamide	2	5.20385793853175e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P43039	10-((1H-indol-3-ylcarbonyl)3,6-dideoxy-alpha-L-arabino-hexopyranosyloxy)-decanoic acid	2	2.98315446328314e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P46641	1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-2-tetradecanoyl-glycero-3-phospho-(1'-myo-inositol)	2	6.42461920172765e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P46656		2	7.27725237770613e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P49606		2	9.3169306865105e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P53070	5-Methyl-4-hydroxy-3-farnesylcoumarin	2	5.61145183719936e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P00330	2-Aminoflubendazole	1	1.19636231360136e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P00889	Diethylene glycol	1	3.24582936825931e-16	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P01269	Viburtinal	1	9.67773913832634e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P01854	Guanosine 2'-monophosphate	1	4.52489822398163e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P03902	Cochlearine	1	4.78451039118046e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P05035		1	8.1128165772216e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P05541	Penthiopyrad	1	4.68813940570935e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P05810	5-(3-(4-(2-(4-Fluorophenyl)ethoxy)phenyl)propyl)furan-2-carboxylic acid	1	9.84317829805275e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P06565	N-[(5-{2-[(6R)-2-Amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-D]pyrimidin-6-YL]ethyl}-2-thienyl)carbonyl]-L-glutamic acid	1	1.26978208262821e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P07947	Valylproline	1	2.81975283996997e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P09386	2-Methyl-5-vinylpyrazine	1	3.33912912900791e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P09580	Diphenylphosphine	1	1.85357747418377e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P09906		1	8.53783474312184e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P10478	Indoline	1	2.03967135090886e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P12066	Sildenafil	1	2.39824089918561e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P12415	Euojaponine C	1	4.56225597047086e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P13915	Centhaquine	1	3.43703398975349e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P14171		1	2.32186897397791e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P14384	(2S)-2-Amino-4-{[(1R)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]amino}butanoate	1	3.7733126377525e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P14757	N(G)-Nitroarginine-4-nitroanilide	1	3.20189825380247e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P15835	AFN911	1	6.07457655694023e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P15837		1	1.94633084494509e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P16079	Funebral	1	3.0994847540843e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P16555	CD 1790	1	7.33518721065129e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P16859	Eterobarb	1	7.60486983131358e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P17647	Quercetin 3-sambubioside-7-glucoside	1	2.76432022760052e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P17761		1	9.36826888395562e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P18970	Deoxypumiloside	1	1.80363236755936e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P19902		1	2.15911235481825e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P20676	3,4,7-Trihydroxy-5-methoxy-8-prenylflavan 4-O-(beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside)	1	7.50037112653389e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P21171	Allanxanthone E	1	8.37415430002793e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P21946		1	7.23554690061568e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P22578		1	1.31849328731288e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P24064		1	7.07873335283999e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P24428	Talniflumate	1	4.5668472610852e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P26278	Miraziridine A	1	9.54625001760214e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P26326		1	9.53056177581503e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P27574	TG(15:0/O-18:0/20:5(5Z,8Z,11Z,14Z,17Z))	1	1.57385782922784e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P27773	3-O-beta-D-Glucopyranosyl hederagenin	1	4.29321524514296e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P27786	Saponarioside M	1	5.35991082856299e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P29257	9R-hydroxy-2S,8S-dimethyl-3-oxo-2E,4E-undecadienoic acid	1	5.09671583858933e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P29538	DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))	1	2.31878091939557e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P30042		1	5.90722869620421e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P30593	GS-3	1	6.8661689571241e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P31152	FD 212	1	7.79670813002871e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P31605	14-Demethyl-14-acetylanhweidelphinine	1	1.35385448486781e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P31683		1	2.5160591055093e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P31816	Eremofortin E	1	1.21502326718016e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P32075	3-O-beta-D-Glucopyranosyl hederagenin	1	7.10043421405971e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P32091	Asprelloside I	1	1.05573413472996e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P32093	Hoodigoside B	1	9.8558303103147e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P32117	Setipafant	1	8.25151807271943e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P32136	Xanthoxoline	1	4.27099888438802e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P32563	6-Methylgingediol	1	1.49183218516338e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P32626	PI(16:2(9Z,12Z)/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))	1	2.00455888999917e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P32646	Antibiotic DC 11A2	1	3.01176516519737e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P32702	Momordin Ia	1	1.16693390489821e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P32895	PA(5-iso PGF2VI/20:4(5Z,8Z,11Z,14Z))	1	9.96034121358632e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P32967	LysoPI(20:0/0:0)	1	3.35366068196754e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P33016		1	7.21574923379435e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P33310	Ternatin C5	1	1.5453334214487e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P34607	PGP(18:1(9Z)/6 keto-PGF1alpha)	1	1.07025789667504e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P34817	Kudinoside D	1	2.06834736399925e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P34836	Alloeremophilone	1	6.81920661221934e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P34864	Tyr-Leu-Tyr-Glu-Ile-Ala-Arg	1	8.6833654484828e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P34871	3-O-beta-D-Glucopyranosyl hederagenin	1	2.50160407997687e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P35026	Bryostatin 10	1	3.99635962923684e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P35069	1-hexadecanoyl-2-succinyl-sn-glycero-phosphocholine	1	2.17690403967312e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P35666	Cibaric acid	1	7.78129231080535e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P35761	3,13-Di-O-beta-D-glucopyranosilgeranyllinalol	1	7.01382089381694e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P35821	[(2R,3S,4R,5R,6R)-2-(Hydroxymethyl)-4,5-bis[[(3R)-3-hydroxytetradecanoyl]amino]-6-phosphonooxyoxan-3-yl] dihydrogen phosphate	1	1.78546188557905e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P35852		1	5.59986224983299e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P35876	PI(18:3(9Z,12Z,15Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))	1	4.49793031100977e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P35973	Soyasaponin aa	1	3.92608000840124e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P35977	Unguisin A	1	2.49436727722603e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P36550	PGP(18:1(9Z)/6 keto-PGF1alpha)	1	1.03115763219478e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P36560	10-Hydroxy-cadin-4-en-3-one	1	2.42335448918733e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P36561	Tragopogonoside A	1	4.83780937784278e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P36562	Phthalsaurediethylhexylester	1	7.03585236246253e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P36564	Alloeremophilone	1	7.58458184154713e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P36585	Crocinervolide	1	4.44772984610965e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P36874		1	4.8149110771122e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P36928	Ligujapone	1	9.47704209339148e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37263		1	3.30958287260457e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37265	PIP(5-iso PGF2VI/18:1(11Z))	1	9.95183573252142e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37266	PIP(22:3(10Z,13Z,16Z)/5-iso PGF2VI)	1	9.18675537710625e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37271	PGP(TXB2/i-15:0)	1	6.12084722781368e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37297	Citrumarin A	1	5.56693638661173e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37308	Semapimod	1	2.0266046219636e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37343	Illifunone C	1	3.74007875612432e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37350	Nobiloside	1	3.49788013917243e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37352	16-{[6-O-acetyl-2-O-(6-O-acetyl-beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}hexadecanolide	1	3.43353393986057e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37510	Latifoloside K	1	1.15490546398375e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37519	Antibiotic A 40A	1	3.65500296283348e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P37528	6beta-(2'-Methylbutanoyloxy)-10beta-hydroxy-8alpha-methoxyeremophil-7(11)-en-12,8beta-olide	1	1.87803227060198e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38129	PGP(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-17:0)	1	3.71995920071698e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38131	Nostocyclopeptide A1	1	4.13105007109797e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38138	Semapimod	1	5.99676316220989e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38150	PIP(22:3(10Z,13Z,16Z)/5-iso PGF2VI)	1	4.41548802460149e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38229		1	2.39697095917814e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38272	4,4-Difluoro-17beta-hydroxyandrost-5-en-3-one propionate	1	7.02682619481212e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38301	1,2-di-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-sn-glycero-3-phospho-(1'-sn-glycerol)	1	5.20032104047142e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38312	Latifoloside K	1	2.1221438170025e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38316	Hoodigoside B	1	8.81673156677345e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38319	Ingenol 3-hexadecanoate	1	8.10582902452796e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38527	Cryptoporic acid E	1	3.21963668190762e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38583	Meliosmoside B	1	5.74992252589176e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38832	1-eicosyl-glycero-3-phosphate	1	8.59503302684712e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38839	Disorazole C1	1	9.07497407479043e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P38859	PGP(PGJ2/18:1(9Z))	1	6.0293227789367e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39463	3-Methoxy-19-norpregna-1,3,5(10)-trien-20-one	1	4.05779427500151e-15	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39611	Landomycin C	1	5.45220725128926e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39615	Hoodigoside B	1	2.8096720250835e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39617	1,2-di-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)	1	6.09634051215382e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39619	PG(20:4(8Z,11Z,14Z,17Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))	1	7.67917504413298e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39622	PA(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	1	7.21828817718803e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39624	1,2-di-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-sn-glycero-3-phospho-(1'-sn-glycerol)	1	8.94095631849095e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39637	5,6-Epoxyoctadeca-7,9-diynoic acid	1	1.81585277480254e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39644	Ingenol 3-hexadecanoate	1	1.40964140505224e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39647	1,10-Epoxy-aristolane	1	6.90179381206436e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39658	(25S)-3-O-(beta-D-xylopyranosyl)-cholest-4-ene-3beta,6beta,8,15alpha,16beta,26-hexaol	1	2.06533942554874e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39722	Pellynol H	1	1.94515471442885e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39753		1	5.54216222320412e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39777	Colubrinoside	1	7.43410722696833e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39803	2,3,4,5-tetranor-9S,11R,15S-trihydroxy-13E-prostenoic acid	1	8.48889516493627e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39979	Basellasaponin D	1	2.80261164227188e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P39997	Avermectin B2b	1	1.87117932325485e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P40001	5,6-Epoxyoctadeca-7,9-diynoic acid	1	6.18377601443699e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P40007	Adhyperforin	1	2.04394732250347e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P40025	Rathbunioside R1	1	2.98546777037103e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P40059	Ingenol 3-hexadecanoate	1	1.36763727684701e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P40157	Cryptoporic acid C	1	7.71676884020856e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P40280	Dymacrin D	1	4.34062477948236e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P40346		1	9.54619726684289e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P40829	2,3-di-O-hexanoyl-alpha-glucopyranose	1	3.38663373739088e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P40835	Gnidicin-20-palmitate	1	4.03777579734414e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P41112		1	2.76011034167837e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P41122		1	5.05793006950902e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P41329	Rebaudioside A	1	2.70868648466773e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P41885	Yayoisaponin C	1	2.60784544150177e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P41961	Officinalisin II	1	8.60553009923872e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P41987		1	7.350982823336e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P41988		1	1.8615237815142e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P41993		1	3.59786944971539e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P41996		1	5.65611534349478e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P41998		1	7.10763632584182e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42050	Arylomycin A5	1	1.3464013725277e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42061	Psychotridine	1	8.58791955517684e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42063	Pectenotoxin 1	1	2.27958554603778e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42093		1	6.30041099871431e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42122	CDP-DG(a-17:0/20:4(5Z,8Z,11Z,14Z)-OH(17))	1	5.44804985196504e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42124		1	1.39970704695566e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42128		1	7.61318240334956e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42130	PIP(18:2(10E,12Z)+=O(9)/20:2(11Z,14Z))	1	2.65389160806172e-15	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42174	Verbesinoside E	1	7.1563274436973e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42317	Officinalisin II	1	3.94429516203463e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42321	N3-Cyclopropyl-7-[(4-propan-2-ylphenyl)methyl]pyrrolo[3,2-f]quinazoline-1,3-diamine	1	2.79720006270224e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42375	Abutiloside D	1	4.06325796544266e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42431		1	1.66364539377619e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42443	(20R)-3beta-hydroxy-D:C-friedoolean-7,9(11)-dien-29-oic acid	1	3.21003822689216e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42671	Benzenepropanoic acid, 4-hydroxy-alpha-(2-((3-(hydroxyamino)-3-oxo-1-(phenylmethyl)propyl)amino)-2-oxoethyl)-3-iodo-	1	5.33470934262845e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42689	PA(22:1(13Z)/LTE4)	1	6.64714748500827e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42709	Ethyl 3-(o-chlorophenyl)-5-methyl-1-phenyl-1h-pyrazole-4-carboxylate	1	4.98101801214567e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42728	PI(20:3(5Z,8Z,14Z)-O(11S,12R)/18:3(9Z,12Z,15Z))	1	1.4381922419904e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42859	4-pregnene-17alpha,20beta,21-triol-3,11-dione	1	7.5365495744679e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42876	Curassavioside D1	1	1.4970042817546e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42897	PG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))	1	8.91290891552965e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P42932		1	5.97686466255973e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P43317	Mutant IDH1 inhibitor	1	3.8955595325666e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P43351		1	2.83161983191291e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P43357	5,6-Epoxyoctadeca-7,9-diynoic acid	1	2.41354679805122e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P43361		1	3.93047255532434e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P43461	PA(LTE4/22:4(7Z,10Z,13Z,16Z))	1	8.63420810023114e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44445	(3b,5a,6b,25R)-3,6-Dihydroxyspirostane-2,12-dione 3-[4'-(2''-glucosyl-3''-xylosyl)-galactoside]	1	7.62999115566419e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44446	PIP(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/22:5(4Z,7Z,10Z,13Z,16Z))	1	1.45895966527367e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44474	4-methylidene-24Z-ethylidene-cholest-5-en-3beta-ol	1	1.15986099134666e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44478	Curassavioside G1	1	5.06127085636316e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44481	1-dodecanoyl-2-tetradecanoyl-glycero-3-phospho-(1'-myo-inositol)	1	5.06983772113431e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44482	3b,15b,17a-Trihydroxy-pregnenone	1	1.27786536962217e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44486	Avermectin B2b	1	2.52408432304843e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44487	PIP(20:0/18:1(12Z)-2OH(9,10))	1	2.57519546540575e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44490	1,2-(8R,9R-epoxy-17E-octadecen-4,6-diynoyl)-3-(8R,9R-epoxy-heptadec-4,6,16-triynoyl)-sn-glycerol	1	1.20214057264893e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44492	Chrysospermin B	1	1.52317566437661e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44493		1	4.79855576494738e-15	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44495		1	1.00011779726209e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44526		1	6.69155200165576e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P44543	Ardisianoside B	1	2.00173749728943e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P45062	Valylproline	1	1.42217385403426e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P45496	2-((5-(Diethylamino)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)(hexyl)amino)ethanol	1	1.33865656138163e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P45744		1	8.3924124078706e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P46667		1	8.46671373009639e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P46797		1	1.98866129936841e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P46924	4,4'-Diapophytofluene	1	2.04766661663638e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P46936	1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phospho-(1'-myo-inositol)	1	8.5978178009755e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P47300		1	7.11679710136991e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P50068	Leucyl-Glycine	1	6.50351250477042e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P52929		1	9.15732835328534e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P53391	NA 30851A	1	8.47283365836635e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P54955	Citronellate	1	1.04487828943095e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135300	P55481		1	1.90788551168018e-11	overlap	1e-10	<	Wm82.a2.v1